StockWatch
·
Pharmaceuticals
Board Meeting17 Oct 2026, 05:30 pm

Zenotech Laboratories Board Meeting on Oct 28 to Approve Unaudited Results

AI Summary

Zenotech Laboratories Ltd has announced that its Board of Directors will convene on October 28, 2026. The primary agenda item is to consider and approve the unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The trading window for the company's shares will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results, extending up to October 30, 2026.

Key Highlights

  • Board meeting scheduled for October 28, 2026.
  • To approve unaudited standalone financial results.
  • Results for the quarter and half-year ended September 30, 2026.
  • Trading window closure until October 30, 2026.